<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230428058019N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-05-25</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>The effect of massage with clove oil on pain and anxiety caused by IT/LP</public_title>
      <acronym></acronym>
      <scientific_title>The effect of effleurage massage with clove oil on IT/LP pain and anxiety among children with cancer: A randomized clinical trial.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-05-07</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>39</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/69994</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The random allocation of participants to each of the study groups and the order of their placement in the groups will be done using the table of random numbers created with the Random Sample Numbers software by the respected Professor of Statistics. The participants will be selected using the available sampling method and will be divided into each group (intervention 1 and 2 and control (without intervention)) by random allocation using the random block method with the software. RAS will be generated, Blinding description: Due to the aromatic nature of clove oil and the ability to differentiate between clove oil and sweet almond oil through smell, blinding is not possible for the researcher and participants, and blinding in this study is only done for the analyst (statistical consultant). will be done, in such a way that they will only know the studied groups in the form of a and b and they will not know which participant will receive which intervention.</study_design>
      <phase>3</phase>
      <hc_freetext>cancer.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:  Intervention group: 1 Working method in intervention group 1 (Effleurage massage group with clove oil) In addition to receiving routine care, this group received effleurage massage with clove oil, which has an analgesic effect to relieve the pain caused by IT/LP. Effleurage massage was performed 15 minutes before IT/LP for 5 minutes. 20 minutes before the child was taken to the procedure room for IT/LP and before the massage therapy, how to use the VAS pain and CAM anxiety measurement tool was explained to the child, and the child's pain and anxiety scores were evaluated based on the tools mentioned was measured. After completing the three-part tool including demographic questionnaire, VAS pain measurement tool and CAM anxiety measurement tool, the patient's basic pain and anxiety before IT/LP procedure and massage intervention were measured and determined. Then, respecting his privacy, the child was placed in a comfortable position on the bed in his room. The waist area was uncovered. Before starting the massage, the hands were warmed and slippery with oil and placed on the skin of the desired area. Then two-handed efflorescence massage was applied using palms and fingers in circular and linear motions in the direction of blood flow from the bottom to the heart and applying low pressure with surface rubbing for 5 minutes depending on the child's tolerance. For massage, clove oil from Shefai Kurdistan Company was used in the amount of 3-4 cc per massage (one third of the dose used in adults for pain relief according to the study of Rahmayanti45). After the massage, 15 minutes were given for the local absorption of the oil and the child was placed in a comfortable position on his bed. After 15 minutes of the massage, the child was taken to the procedure room and the IT/LP procedure was performed on him by the doctor. 3 minutes after the completion of IT/LP, according to the general state of the child and before the child leaves the procedure room, the pain score experienced by the child during IT/LP using the VAS tool and the anxiety score experienced during the IT/LP procedure LP was evaluated and determined using the CAM tool. Intervention 2: Intervention group:  In intervention group 2 (Effleurage massage with sweet almond oil), this group also received exfoliation massage with sweet almond oil in addition to receiving routine care. Massage was done 15 minutes before IT/LP for 5 minutes. According to the study of Batalha40, sweet almond oil, which does not have many analgesic properties, was used as a placebo in intervention group 2. In this study, sweet almond oil was used by Barij Essans Pharmaceutical Company. Effleurage massage was performed 15 minutes before IT/LP for 5 minutes. 20 minutes before the child was taken to the procedure room for IT/LP and before the massage therapy, how to use the VAS pain and CAM anxiety measurement tool was explained to the child, and the child's pain and anxiety scores were evaluated based on the tools mentioned was measured. After completing the three-part tool including demographic questionnaire, VAS pain measurement tool and CAM anxiety measurement tool, the patient's basic pain and anxiety before IT/LP procedure and massage intervention were measured and determined. Then, respecting his privacy, the child was placed in a comfortable position on the bed in his room. The waist area was uncovered. Before starting the massage, the hands were warmed and slippery with oil and placed on the skin of the desired area. Then two-handed efflorescence massage was applied using palms and fingers in circular and linear motions in the direction of blood flow from the bottom to the heart and applying low pressure with surface rubbing for 5 minutes depending on the child's tolerance. For massage, 3-4 cc of sweet almond oil was used for each massage (one third of the dose used in adults for pain relief according to the study of Rahmayanti45). After the massage, 15 minutes were given for the local absorption of the oil and the child was placed in a comfortable position on his bed. After 15 minutes of the massage, the child was taken to the procedure room and the IT/LP procedure was performed on him by the doctor. 3 minutes after the completion of IT/LP, according to the general state of the child and before the child leaves the procedure room, the pain score experienced by the child during IT/LP using the VAS tool and the anxiety score experienced during the IT/LP procedure LP was evaluated and determined using the CAM tool. Intervention 3: Control group: Working method in the control group (without intervention), this group only received routine care before, during and after the IT/LP procedure, and no intervention was done by the researcher, and only the assessment of pain and anxiety before and after the procedure with tools It was mentioned and it was done and recorded in the mentioned times like the groups of intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Demographic characteristics of subjects and pain and anxiety scores during the intervention

When:
"Starting the access period 6 months after printing the results"

To whom:
Researchers working in academia and industry

Conditions:
It is possible to use the data with the permission of the researcher and citing the study.

Where to obtain:
The full name of the responsible person Leila Valizadeh email fatemehrahimi028@gmail.com job position Professor Street Address Tabriz / Southern Shariati Street / College of Nursing and Midwifery City Tabriz State East Azarbaijan Country Islamic Republic of Iran Postal code 5178763914 Phone +98 41 3477 0649 Cellular phone +98 921 715 5629

How to obtain:
It takes about a month to send an email to the responsible person and review the request by him.(masculine)

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Leila Valizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tabriz / Southern Shariati Street / College of Nursing and Midwifery</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5178763914</zip>
        <telephone>+98 41 3477 0649</telephone>
        <email>fatemehrahimi028@gmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Leila Valizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tabriz / Southern Shariati Street / College of Nursing and Midwifery</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5178763914</zip>
        <telephone>+98 41 3477 0649</telephone>
        <email>fatemehrahimi028@gmail.com</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Definitive diagnosis of cancer and hospitalization in the ward .
Prescribing LP and receiving IT
Children aged 7 to 11 years</inclusion_criteria>
      <agemin>7 years</agemin>
      <agemax>11 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. The order to receive midazolam or other sedatives before the procedure
2. The child's restlessness and intolerance of research conditions
3. Loss of consciousness and lack of awareness of time, place and person
4. Severely ill and end-stage child
5. The need to observe contact precautions
6. Fever, risk of bleeding (platelet count less than 20,000), leukopenia
7. Inability to communicate verbally (deafness) and vision disorders and physical defects, Down's syndrome and genetic diseases that disrupt the expression and experience of pain. Having a wound, fracture, infection, redness and abnormal swelling in the massage area
8. People undergoing IT/LP for the first time.
History of allergy to clove and sweet almond oil</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>C90</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Multiple myeloma and malignant plasma cell neoplasms</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:  Intervention group: 1 Working method in intervention group 1 (Effleurage massage group with clove oil) In addition to receiving routine care, this group received effleurage massage with clove oil, which has an analgesic effect to relieve the pain caused by IT/LP. Effleurage massage was performed 15 minutes before IT/LP for 5 minutes. 20 minutes before the child was taken to the procedure room for IT/LP and before the massage therapy, how to use the VAS pain and CAM anxiety measurement tool was explained to the child, and the child's pain and anxiety scores were evaluated based on the tools mentioned was measured. After completing the three-part tool including demographic questionnaire, VAS pain measurement tool and CAM anxiety measurement tool, the patient's basic pain and anxiety before IT/LP procedure and massage intervention were measured and determined. Then, respecting his privacy, the child was placed in a comfortable position on the bed in his room. The waist area was uncovered. Before starting the massage, the hands were warmed and slippery with oil and placed on the skin of the desired area. Then two-handed efflorescence massage was applied using palms and fingers in circular and linear motions in the direction of blood flow from the bottom to the heart and applying low pressure with surface rubbing for 5 minutes depending on the child's tolerance. For massage, clove oil from Shefai Kurdistan Company was used in the amount of 3-4 cc per massage (one third of the dose used in adults for pain relief according to the study of Rahmayanti45). After the massage, 15 minutes were given for the local absorption of the oil and the child was placed in a comfortable position on his bed. After 15 minutes of the massage, the child was taken to the procedure room and the IT/LP procedure was performed on him by the doctor. 3 minutes after the completion of IT/LP, according to the general state of the child and before the child leaves the procedure room, the pain score experienced by the child during IT/LP using the VAS tool and the anxiety score experienced during the IT/LP procedure LP was evaluated and determined using the CAM tool.</i_keyword>
      <i_keyword>Intervention group:  In intervention group 2 (Effleurage massage with sweet almond oil), this group also received exfoliation massage with sweet almond oil in addition to receiving routine care. Massage was done 15 minutes before IT/LP for 5 minutes. According to the study of Batalha40, sweet almond oil, which does not have many analgesic properties, was used as a placebo in intervention group 2. In this study, sweet almond oil was used by Barij Essans Pharmaceutical Company. Effleurage massage was performed 15 minutes before IT/LP for 5 minutes. 20 minutes before the child was taken to the procedure room for IT/LP and before the massage therapy, how to use the VAS pain and CAM anxiety measurement tool was explained to the child, and the child's pain and anxiety scores were evaluated based on the tools mentioned was measured. After completing the three-part tool including demographic questionnaire, VAS pain measurement tool and CAM anxiety measurement tool, the patient's basic pain and anxiety before IT/LP procedure and massage intervention were measured and determined. Then, respecting his privacy, the child was placed in a comfortable position on the bed in his room. The waist area was uncovered. Before starting the massage, the hands were warmed and slippery with oil and placed on the skin of the desired area. Then two-handed efflorescence massage was applied using palms and fingers in circular and linear motions in the direction of blood flow from the bottom to the heart and applying low pressure with surface rubbing for 5 minutes depending on the child's tolerance. For massage, 3-4 cc of sweet almond oil was used for each massage (one third of the dose used in adults for pain relief according to the study of Rahmayanti45). After the massage, 15 minutes were given for the local absorption of the oil and the child was placed in a comfortable position on his bed. After 15 minutes of the massage, the child was taken to the procedure room and the IT/LP procedure was performed on him by the doctor. 3 minutes after the completion of IT/LP, according to the general state of the child and before the child leaves the procedure room, the pain score experienced by the child during IT/LP using the VAS tool and the anxiety score experienced during the IT/LP procedure LP was evaluated and determined using the CAM tool.</i_keyword>
      <i_keyword>Control group: Working method in the control group (without intervention), this group only received routine care before, during and after the IT/LP procedure, and no intervention was done by the researcher, and only the assessment of pain and anxiety before and after the procedure with tools It was mentioned and it was done and recorded in the mentioned times like the groups of intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: The pain variable will be evaluated 20 minutes before the intervention and 3 minutes after the intervention. Method of measurement: visual analog scale  of pain.</prim_outcome>
      <prim_outcome>Anxiety. Timepoint: The anxiety variable will be evaluated 20 minutes before the intervention and 3 minutes after the intervention. Method of measurement: Children’s Anxiety Meter-Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-01-11</approval_date>
        <contact_name>Research Ethics Committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Resalat, No. 66, Koche Eskoi, Sosangerd Street Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
